Christopher Benecchi
2021
Compensation breakdown
| Bonus | $200,000 |
|---|---|
| Non-Equity Incentive Plan | $55,699 |
| Option Awards | $1,324,058 |
| Salary | $133,334 |
| Stock Awards | $1,019,025 |
| Other | $314 |
| Total | $2,732,430 |
Benecchi received $1.3M in option awards, accounting for 48% of the total pay in 2021.
Benecchi also received $200K in bonus, $55.7K in non-equity incentive plan, $133.3K in salary, $1M in stock awards and $314 in other compensation.
Rankings
In 2021, Christopher Benecchi's compensation ranked 4,800th out of 12,405 executives tracked by ExecPay. In other words, Benecchi earned more than 61.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,800 out of 12,405 | 61st |
Division Manufacturing | 2,005 out of 5,494 | 64th |
Major group Chemicals And Allied Products | 848 out of 2,369 | 64th |
Industry group Drugs | 758 out of 2,090 | 64th |
Industry Pharmaceutical Preparations | 541 out of 1,537 | 65th |
Pay ratio
| Christopher Benecchi's Pay | $2,732,430 |
|---|---|
| Median Employee's Pay | $308,210 |
| Pay Ratio | 9to 1 |
In 2021, the annual total compensation of Christopher Benecchi was $2,732,430.
The annual total compensation of the median employee at Sage Therapeutics was $308,210.
The ratio of Christopher Benecchi's pay to the pay of median employee was therefore 9 to one.
Benecchi's colleagues
We found four more compensation records of executives who worked with Christopher Benecchi at Sage Therapeutics in 2021.